Aerobic glycolysis has been the most important hypothesis in cancer metabolism. It seems to be related to increased bioenergetic and biosynthetic needs in rapidly proliferating cancer cells. To this end, F-18 fluorodeoxyglucose (FDG), a glucose analog, became widely popular for the detection of malignancies combined with positron emission tomography/computed tomography (PET/CT). Although the potential roles of FDG PET/CT in primary tumor detection are not fully established, it seems to have a limited sensitivity in detecting early gastric cancer and mainly signet ring or non-solid types of advanced gastric cancer. In evaluating lymph node metastases, the location of lymph nodes and the degree of FDG uptake in primary tumors appear to be important factors affecting the diagnostic accuracy of PET/ CT. In spite of the limited sensitivity, the high specificity of PET/CT for lymph node metastases may play an important role in changing the extent of lymphadenectomy or reducing futile laparotomies. For peritoneal metastases, PET/CT seems to have a poorer sensitivity but a better specificity than CT. The roles of PET/CT in the evaluation of other distant metastases are yet to be known. Studies including primary tumors with low FDG uptake or peritoneal recurrence seem suffer from poorer diagnostic performance for the detection of recurrent gastric cancer. There are only a few reports using FDG PET/CT to predict response to neoadjuvant or adjuvant chemotherapy. A complete metabolic response seems to be predictive of more favorable prognosis.
Introduction
In 1920s, Warburg et al. 1 reported a phenomenon that cancer cells are dependent on glycolysis even in the presence of oxygen which is likely due to the impaired function of mitochondria. Since then, this Warburg effect has been the most important hypothesis in studying cancer metabolism and is considered as a seventh hallmark of human cancers. 2 Aerobic glycolysis was originally attributable to increased bioenergetic needs in rapidly proliferating cancer 1 ). There can be significant amounts of physiologic FDG uptake in the stomach which mimics pathology. Simple distention of the stomach using water reduces physiologic uptake and improves the diagnostic performance of PET/CT in detecting and localizing primary tumors, and assessing the degree of FDG uptake in gastric cancers. [12] [13] [14] 15 However, a wide spectrum of FDG uptake from low to intense is also seen in poorly differentiated adenocarcinomas. Other factors besides histologic differentiation seem important in determining FDG uptake in adenocarcinomas of poorly differentiated type. 5 Overall, PET/CT has a limited sensitivity in detecting EGC and some types of advanced gastric cancer (AGC) as discussed above.
One of the benefits on PET/CT is in the prediction of biological aggressiveness and/or patient prognosis on the basis of the metabolic activity of primary tumors. There are controversial, limited data whether the degree of FDG uptake on PET/CT is predictive of patient prognosis. 3, [16] [17] [18] [19] [20] Some reported a longer survival in patients with negative PET than those with positive PET whereas others could not find any difference in survival rate between patients with high FDG uptake and those with low FDG uptake. Studies by histopathological subtypes seem to give better information on the association between FDG uptake and patient prognosis. 18, 20 In our study assessing 41 patients with curative gastrectomy for advanced signet ring cell carcinoma, with a cutoff standardized uptake value (SUV) of 3.8, the high SUV group showed more aggressive tumor behavior than did the low SUV group. 18 The high SUV group also had more postoperative recurrence, shorter relapse free survival, and lower 30 months cancer specific survival rates although SUV
was not an independent predictor of overall survival.
TNM Staging
Accurate staging is essential in selecting optimal management plan for the patients preoperatively. The role of PET/CT is limited in T staging of primary tumors due to its low spatial resolution preventing the evaluation of adjacent organ invasion. The presence CT in detecting peritoneal metastases (Fig. 2) . For the evaluation of other distant metastases including the liver, bone, lung, adrenal gland, or etc, the roles of PET/CT are yet to be known. A recent study reported that PET/CT detects occult metastases in about 10%
of patients with AGC. 23 They suggested PET/CT to be a component of the standard staging algorithm for AGC due to reduced morbidity from fewer futile operations and lower patient care costs.
Detection of Recurrent Tumors
Common locations of recurrence after initial surgery include locoregional areas, peritoneum, extra-abdominal lymph nodes, and hematogenous spread to distant sites. Although contrast CT is most commonly used in detecting recurrence, its accuracy can be com- A complete metabolic response on FDG PET seems to be predictive of more favorable prognosis.
